CardiacSense: Funding, Investors & Team (Sep 2026)
CardiacSense is an innovative start-up on track to revolutionize the Wearable Health Industry by providing affordable, comfortable FDA & CE certified Medical Watches and Wristbands capable of continuous, long term, ambulatory and non-invasive monitoring of life critical functions including Heart Rate, Pulse Rate, Respiratory Rate, Core Temperature, Oxygen Saturation and Blood Pressure. These capabilities enable accurate real time diagnostics of medical conditions such as Heart Arrhythmias (incl. Atrial Fibrillation), Hypertension, COPD, Heart Failure, Sleep Apnea and infections (such as COVID-19).
CardiacSense has raised $1.5M across 1 funding round on record, the most recent a Series A of $1.5M announced in Feb 2021.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
CardiacSense Company Profile and Key Stats
Latest funding round on record: Feb 2021.
CardiacSense Funding Rounds
CardiacSense Founders and Leadership Team
Contact details for the CardiacSense team: 1 of 1 has an email address on file.
Start 14-day free trial →CardiacSense Funding Compared to Other Biotechnology Startups
CardiacSense's latest round of $1.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like CardiacSense in Biotechnology and Caesarea
Companies Similar to CardiacSense
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
CardiacSense Funding FAQs
What does CardiacSense do?
CardiacSense is an innovative start-up on track to revolutionize the Wearable Health Industry by providing affordable, comfortable FDA & CE certified Medical Watches and Wristbands capable of continuous, long term, ambulatory and non-invasive monitoring of life critical functions including Heart Rate, Pulse Rate, Respiratory Rate, Core Temperature, Oxygen Saturation and Blood Pressure. These capabilities enable accurate real time diagnostics of medical conditions such as Heart Arrhythmias (incl. Atrial Fibrillation), Hypertension, COPD, Heart Failure, Sleep Apnea and infections (such as COVID-19).
How much funding has CardiacSense raised?
CardiacSense has raised $1.5M across 1 round on record. The most recent is a Series A of $1.5M announced in Feb 2021.
When did CardiacSense last raise funding?
CardiacSense's most recent funding round on record is a Series A of $1.5M, announced in Feb 2021.
Who is the CEO of CardiacSense?
Eldad Shemesh is listed as CEO at CardiacSense.
Where is CardiacSense headquartered?
CardiacSense is based in Caesarea, Hefa, Israel.
How many employees does CardiacSense have?
CardiacSense is in the 11-50 employee band.
How does CardiacSense's funding compare to other Biotechnology startups?
CardiacSense's latest round of $1.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's CardiacSense Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CardiacSense is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.